Sight Diagnostics, an Israeli medical devices startup that’s using AI technology to speed up blood testing, has closed a $27.8 million Series C funding round.
Read more here.
![[CytoReason in Outsourcing Pharma] Is artificial intelligence the best tool for drug discovery?](https://blog.mktg.ocdvlp.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
[CytoReason in Outsourcing Pharma] Is artificial intelligence the best tool for drug discovery?
December 7, 2021
[D-ID in Forbes] D-ID: This Start-Up’s Betting Synthetic Media Can Democratize Content Creation In The Age Of Privacy
March 3, 2021
